US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist
  • 37.900
  • -0.050-0.13%
Close May 28 16:00 ET
6.25BMarket Cap-9869P/E (TTM)

Revolution Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-67.27%11.58M
-95.16%742K
0
-58.05%3.82M
-7.44%7.01M
20.38%35.38M
62.05%15.33M
204.81%3.36M
4.81%9.12M
Operating revenue
--0
-67.27%11.58M
-95.16%742K
--0
-58.05%3.82M
-7.44%7.01M
20.38%35.38M
62.05%15.33M
204.81%3.36M
4.81%9.12M
Cost of revenue
Gross profit
Operating expense
71.42%140.86M
69.84%498.77M
134.60%180.73M
54.27%123.25M
58.16%112.62M
25.40%82.17M
35.08%293.66M
23.51%77.04M
47.22%79.89M
33.76%71.21M
Selling and administrative expenses
72.70%22.84M
86.32%75.62M
195.55%32.24M
48.68%15.51M
43.47%14.64M
46.33%13.22M
33.29%40.59M
25.52%10.91M
33.92%10.43M
39.84%10.2M
-General and administrative expense
72.70%22.84M
86.32%75.62M
195.55%32.24M
48.68%15.51M
43.47%14.64M
46.33%13.22M
33.29%40.59M
25.52%10.91M
33.92%10.43M
39.84%10.2M
Research and development costs
71.18%118.02M
67.20%423.14M
124.54%148.48M
55.11%107.74M
60.62%97.98M
22.05%68.95M
35.37%253.07M
23.19%66.13M
49.45%69.46M
32.80%61M
Operating profit
-87.42%-140.86M
-88.63%-487.19M
-191.67%-179.98M
-61.04%-123.25M
-75.23%-108.8M
-29.70%-75.16M
-37.38%-258.28M
-16.62%-61.71M
-43.96%-76.53M
-39.42%-62.09M
Net non-operating interest income expense
236.59%23.76M
415.39%47.18M
267.82%18.67M
276.57%10.95M
1,110.96%10.5M
2,237.42%7.06M
898.26%9.15M
2,042.19%5.08M
1,203.59%2.91M
267.37%867K
Non-operating interest income
236.59%23.76M
418.70%47.48M
273.78%18.98M
276.57%10.95M
1,110.96%10.5M
2,237.42%7.06M
885.36%9.15M
2,042.19%5.08M
1,203.59%2.91M
267.37%867K
Non-operating interest expense
----
--303K
----
----
----
----
--0
----
----
----
Other net income (expense)
1.1M
115K
Gain on sale of security
--3.91M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
---2.81M
--115K
----
----
----
----
----
----
----
----
Income before tax
-70.35%-116M
-76.57%-439.89M
-184.64%-161.19M
-52.53%-112.3M
-60.56%-98.3M
-18.13%-68.1M
-33.16%-249.13M
-7.51%-56.63M
-39.07%-73.63M
-38.20%-61.22M
Income tax
0
-739.05%-3.52M
378.86%343K
-1,202.02%-3.87M
0
0
-420K
-123K
-297K
0
Net income
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
Net income continuous Operations
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
Minority interest income
Net income attributable to the parent company
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
-38.20%-61.22M
Basic earnings per share
2.78%-0.7
-25.32%-3.86
-92.06%-1.21
-13.79%-0.99
-12.20%-0.92
7.69%-0.72
-19.84%-3.08
11.27%-0.63
-20.83%-0.87
-36.67%-0.82
Diluted earnings per share
2.78%-0.7
-25.32%-3.86
-92.06%-1.21
-13.79%-0.99
-12.20%-0.92
7.69%-0.72
-19.84%-3.08
11.27%-0.63
-20.83%-0.87
-36.67%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-67.27%11.58M-95.16%742K0-58.05%3.82M-7.44%7.01M20.38%35.38M62.05%15.33M204.81%3.36M4.81%9.12M
Operating revenue --0-67.27%11.58M-95.16%742K--0-58.05%3.82M-7.44%7.01M20.38%35.38M62.05%15.33M204.81%3.36M4.81%9.12M
Cost of revenue
Gross profit
Operating expense 71.42%140.86M69.84%498.77M134.60%180.73M54.27%123.25M58.16%112.62M25.40%82.17M35.08%293.66M23.51%77.04M47.22%79.89M33.76%71.21M
Selling and administrative expenses 72.70%22.84M86.32%75.62M195.55%32.24M48.68%15.51M43.47%14.64M46.33%13.22M33.29%40.59M25.52%10.91M33.92%10.43M39.84%10.2M
-General and administrative expense 72.70%22.84M86.32%75.62M195.55%32.24M48.68%15.51M43.47%14.64M46.33%13.22M33.29%40.59M25.52%10.91M33.92%10.43M39.84%10.2M
Research and development costs 71.18%118.02M67.20%423.14M124.54%148.48M55.11%107.74M60.62%97.98M22.05%68.95M35.37%253.07M23.19%66.13M49.45%69.46M32.80%61M
Operating profit -87.42%-140.86M-88.63%-487.19M-191.67%-179.98M-61.04%-123.25M-75.23%-108.8M-29.70%-75.16M-37.38%-258.28M-16.62%-61.71M-43.96%-76.53M-39.42%-62.09M
Net non-operating interest income expense 236.59%23.76M415.39%47.18M267.82%18.67M276.57%10.95M1,110.96%10.5M2,237.42%7.06M898.26%9.15M2,042.19%5.08M1,203.59%2.91M267.37%867K
Non-operating interest income 236.59%23.76M418.70%47.48M273.78%18.98M276.57%10.95M1,110.96%10.5M2,237.42%7.06M885.36%9.15M2,042.19%5.08M1,203.59%2.91M267.37%867K
Non-operating interest expense ------303K------------------0------------
Other net income (expense) 1.1M115K
Gain on sale of security --3.91M------------------------------------
Other non- operating income (expenses) ---2.81M--115K--------------------------------
Income before tax -70.35%-116M-76.57%-439.89M-184.64%-161.19M-52.53%-112.3M-60.56%-98.3M-18.13%-68.1M-33.16%-249.13M-7.51%-56.63M-39.07%-73.63M-38.20%-61.22M
Income tax 0-739.05%-3.52M378.86%343K-1,202.02%-3.87M00-420K-123K-297K0
Net income -70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M-38.20%-61.22M
Net income continuous Operations -70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M-38.20%-61.22M
Minority interest income
Net income attributable to the parent company -70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M-38.20%-61.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M-38.20%-61.22M
Basic earnings per share 2.78%-0.7-25.32%-3.86-92.06%-1.21-13.79%-0.99-12.20%-0.927.69%-0.72-19.84%-3.0811.27%-0.63-20.83%-0.87-36.67%-0.82
Diluted earnings per share 2.78%-0.7-25.32%-3.86-92.06%-1.21-13.79%-0.99-12.20%-0.927.69%-0.72-19.84%-3.0811.27%-0.63-20.83%-0.87-36.67%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg